Gabapentin Capsule
Product Images NDC 82804-226

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-226). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure diagram of Gabapentin showing the molecular arrangement with cyclohexane ring bonded to amino and carboxyl functional groups.*

FDA Label Image

Figure 1 (Gabapenin 02)

A line graph illustrating mean pain scores over an 8-week period comparing Gabapentin 3,600 mg/day to placebo. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend compared to placebo.*

FDA Label Image

Figure 2 (Gabapenin 03)

A line graph showing mean pain scores over a 7-week period comparing placebo with Gabapentin at doses of 1,800 mg/day and 2,400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, illustrating changes in pain scores from baseline through week 7.*

FDA Label Image

Figure 3 (Gabapenin 04)

A bar chart comparing the percentage outcomes of two studies. Study 1 shows results for placebo (PBO) at 12% and gabapentin (GBP) at 3,600 mg with 29%. Study 2 includes placebo at 14%, gabapentin 1,800 mg at 32%, and gabapentin 2,400 mg at 34%. Statistical significance is indicated with ** for p<0.01 and *** for p<0.001.*

FDA Label Image

Figure 4 (Gabapenin 05)

A scatter plot chart showing daily dose (mg) on the x-axis and percentage difference (%) on the y-axis. The chart compares data points from three studies labeled as STUDY a, STUDY b, and STUDY c, with distinct markers for each study. The data points are distributed across daily doses ranging from 600 mg to 1800 mg, with corresponding percentage differences from approximately 2% to 22%.*

FDA Label Image

82804-226-30 (Gabapenin 06)

Label for Gabapentin 100 mg capsules by Proficient Rx LP. The label indicates a package size of 30 capsules and displays NDC 82804-226-30. It states each capsule contains 100 mg of gabapentin, USP, with imprint details. Manufacturer is CSPC Ouyi Pharmaceutical Co., Ltd., China. Storage instructions and safety warnings are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.